Stock page
Breathe BioMedical Inc (BRTH)
Breathe BioMedical Inc is developing a platform technology designed to detect diseases in exhaled breath. Its focus is to create a breath test that could make the early detection of breast cancer in women with dense breast tissue, as easy as breathing. The company product include Breathe BioMedical Breath Sampler Technology.
Quote snapshot
$0.00
Daily change: —
ExchangeNAS
Updated2026-05-09T04:29:12.861769Z
Price chart
Price history
| Name |
|---|
| Revenue |
| Cost Of Goods Sold |
| Gross Profit |
| Gross Margin % |
| Research Development |
| Selling General Admin Expense |
| Depreciation Depletion Amortization |
| Other Operating Expense |
| Total Operating Expense |
| Operating Income |
| Operating Margin |
| Interest Income |
| Interest Expense |
| Other Income Expense |
| Other Income Minority Interest |
| Other Net Income Loss |
| Ebit |
| Ebitda |
| Ebitda Margin |
| Pretax Income |
| Tax Provision |
| Tax Rate |
| Net Income Continuing Operations |
| Net Income Discontinued Operations |
| Net Income |
| Net Income Including Noncontrolling Interests |
| Is Preferred Dividends |
| Shares Outstanding |
| Eps Basic |
| Eps Diluted |
| Net Margin |
SEC filings
Latest 10-K filing table
| Date | Form | Accession | Link |
|---|